The WACC of Impel Neuropharma Inc (IMPL) is 5.7%.
| Range | Selected | |
| Cost of equity | 88.40% - 124.70% | 106.55% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.3% - 6.0% | 5.7% |
| Category | Low | High |
| Long-term bond rate | 4.2% | 4.7% |
| Equity market risk premium | 5.0% | 6.0% |
| Adjusted beta | 16.84 | 19.93 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 88.40% | 124.70% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 50.28 | 50.28 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.3% | 6.0% |
| Selected WACC | 5.7% | |